RCMI Coordinating Center (RCMI CC) Header Logo

Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer.

Minas TZ, Candia J, Dorsey TH, Baker F, Tang W, Kiely M, Smith CJ, Zhang AL, Jordan SV, Obadi OM, Ajao A, Tettey Y, Biritwum RB, Adjei AA, Mensah JE, Hoover RN, Jenkins FJ, Kittles R, Hsing AW, Wang XW, Loffredo CA, Yates C, Cook MB, Ambs S. Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer. Nat Commun. 2022 04 01; 13(1):1759.

View in: PubMed

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support